Company Filing History:
Years Active: 1998-2000
Title: Innovations by Yan Cao in Monospecific Antibodies
Introduction
Yan Cao is an accomplished inventor based in Valhalla, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of monospecific antibodies. With a total of 3 patents, his work has the potential to impact various medical diagnostics and therapeutic applications.
Latest Patents
One of Yan Cao's latest patents focuses on monospecific antibodies against a subunit of fibrinogen. This invention provides antibodies that are specifically reactive with the .alpha.E subunit of fibrinogen or its fragments, while not interacting with other portions of the fibrinogen molecule. The patent also includes anti-.alpha.E probes, which consist of detectably labeled monospecific anti-.alpha.E antibodies. Furthermore, the invention outlines methods for using these antibodies to detect the .alpha.E subunit and its fragments, along with reagents and kits for performing these methods. The diagnostic methods developed can determine information related to atherogenesis, thrombogenesis, and pregnancy status or outcomes. Additionally, the invention offers continuous cell lines that produce monospecific anti-.alpha.E antibodies.
Career Highlights
Yan Cao is currently associated with the New York Blood Center, Inc., where he continues to advance his research and innovations. His work is pivotal in enhancing the understanding and treatment of various medical conditions through the use of advanced antibody technologies.
Collaborations
Yan has collaborated with notable colleagues, including Gerd Grieninger and Yiping Fu, who contribute to the innovative environment in which he works.
Conclusion
Yan Cao's contributions to the field of biotechnology, particularly through his patents on monospecific antibodies, demonstrate his commitment to advancing medical science. His work has the potential to lead to significant improvements in diagnostic methods and therapeutic strategies.